Glucose metabolic reprogramming in autoimmune diseases

References

• Abboud G, Choi S, Kanda N, Zeumer-Spataro L, Roopenian DC, Morel L. 2018. Inhibition of glycolysis reduces disease severity in an autoimmune model of rheumatoid arthritis. Front Immunol. 9. doi:10.3389/fimmu.2018.01973.
   Web of Science ®Google Scholar
• Andrejeva G, Rathmell JC. 2017. Similarities and distinctions of cancer and immune metabolism in inflammation and tumors. Cell Metab. 26(1):49–70. doi:10.1016/j.cmet.2017.06.004.
   PubMed Web of Science ®Google Scholar
• Andreucci E, Margheri F, Peppicelli S, Bianchini F, Ruzzolini J, Laurenzana A, Fibbi G, Bruni C, Bellando-Randone S, Guiducci S, et al. 2021. Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis. Rheumatology. 60(10):4508–4519. doi:10.1093/rheumatology/keab022.
   PubMed Web of Science ®Google Scholar
• Biniecka M, Canavan M, McGarry T, Gao W, McCormick J, Cregan S, Gallagher L, Smith T, Phelan JJ, Ryan J, et al. 2016. Dysregulated bioenergetics: a key regulator of joint inflammation. Ann Rheum Dis. 75(12):2192–2200. doi:10.1136/annrheumdis-2015-208476.
   PubMed Web of Science ®Google Scholar
• Braidy N, Lim CK, Grant R, Brew BJ, Guillemin GJ. 2013. Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis. Brain Res. 1537:267–272. doi:10.1016/j.brainres.2013.08.025.
   PubMed Web of Science ®Google Scholar
• Burrack AL, Martinov T, Fife BT. 2017. T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes. Front Endocrinol (Lausanne). 8:343. doi:10.3389/fendo.2017.00343.
   PubMed Web of Science ®Google Scholar
• Bustamante MF, Oliveira PG, Garcia-Carbonell R, Croft AP, Smith JM, Serrano RL, Sanchez-Lopez E, Liu X, Kisseleva T, Hay N, et al. 2018. Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis. Ann Rheum Dis. 77(11):1636–1643. doi:10.1136/annrheumdis-2018-213103.
   PubMed Web of Science ®Google Scholar
• Chang C-H, Curtis JD, Maggi LB, Faubert B, Villarino AV, O’Sullivan D, Huang SC-C, van der Windt GJW, Blagih J, Qiu J, et al. 2013. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 153(6):1239–1251. doi:10.1016/j.cell.2013.05.016.
   PubMed Web of Science ®Google Scholar
• Chang X, Wei C. 2011. Glycolysis and rheumatoid arthritis. Int J Rheum Dis. 14(3):217–222. doi:10.1111/j.1756-185X.2011.01598.x.
   PubMed Web of Science ®Google Scholar
• Chen H, Yang T, Zhu L, Zhao Y. 2015. Cellular metabolism on T-cell development and function. Int Rev Immunol. 34(1):19–33. doi:10.3109/08830185.2014.902452.
   PubMed Web of Science ®Google Scholar
• Chen J, Chernatynskaya AV, Li J-W, Kimbrell MR, Cassidy RJ, Perry DJ, Muir AB, Atkinson MA, Brusko TM, Mathews CE. 2017. T cells display mitochondria hyperpolarization in human type 1 diabetes. Sci Rep. 7(1):10835. doi:10.1038/s41598-017-11056-9.
   PubMedGoogle Scholar
• Chen W, Zhang J, Zhong W, Liu Y, Lu Y, Zeng Z, Huang H, Wan X, Meng X, Zou F, et al. 2021. Anlotinib inhibits PFKFB3-driven glycolysis in myofibroblasts to reverse pulmonary fibrosis. Front Pharmacol. 12. doi:10.3389/fphar.2021.744826.
   Web of Science ®Google Scholar
• Chou W-C, Rampanelli E, Li X, Ting JP-Y. 2022. Impact of intracellular innate immune receptors on immunometabolism. Cell Mol Immunol. 19(3):337–351. doi:10.1038/s41423-021-00780-y.
   PubMed Web of Science ®Google Scholar
• De Riccardis L, Ferramosca A, Danieli A, Trianni G, Zara V, De Robertis F, Maffia M. 2016. Metabolic response to glatiramer acetate therapy in multiple sclerosis patients. BBA Clin. 6:131–137. doi:10.1016/j.bbacli.2016.10.004.
   PubMedGoogle Scholar
• Dierckx T, Vanherle S, Haidar M, Grajchen E, Mingneau F, Gervois P, Wolfs E, Bylemans D, Voet A, Nguyen T, et al. 2022. Phloretin enhances remyelination by stimulating oligodendrocyte precursor cell differentiation. Proc Natl Acad Sci USA. 119(46):e2120393119. doi:10.1073/pnas.2120393119.
   PubMed Web of Science ®Google Scholar
• Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, et al. 2017. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 76(11):1897–1905. doi:10.1136/annrheumdis-2017-211448.
   PubMed Web of Science ®Google Scholar
• Fearon U, Hanlon MM, Floudas A, Veale DJ. 2022. Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications. Nat Rev Rheumatol. 18(7):398–414. doi:10.1038/s41584-022-00771-x.
   PubMed Web of Science ®Google Scholar
• Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, Elstrom RL, June CH, Thompson CB. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity. 16(6):769–777. doi:10.1016/S1074-7613(02)00323-0.
   PubMed Web of Science ®Google Scholar
• Ganeshan K, Chawla A. 2014. Metabolic regulation of immune responses. Annu Rev Immunol. 32:609–634. doi:10.1146/annurev-immunol-032713-120236.
   PubMed Web of Science ®Google Scholar
• Garcia-Carbonell R, Divakaruni AS, Lodi A, Vicente-Suarez I, Saha A, Cheroutre H, Boss GR, Tiziani S, Murphy AN, Guma M. 2016. Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol. 68(7):1614–1626. doi:10.1002/art.39608.
   PubMed Web of Science ®Google Scholar
• Gergely P, Jr., Grossman C, Niland B, Puskas F, Neupane H, Allam F, Banki K, Phillips PE, Perl A. 2002. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 46(1):175–190. doi:10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H.
   PubMed Web of Science ®Google Scholar
• Gergely P, Jr, Niland B, Gonchoroff N, Pullmann R, Jr, Phillips PE, Perl A. 2002. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J Immunol. 169(2):1092–1101. doi:10.4049/jimmunol.169.2.1092.
   PubMed Web of Science ®Google Scholar
• Gerriets VA, Kishton RJ, MO J, Cohen S, Siska PJ, Nichols AG, Warmoes MO, de Cubas AA, MacIver NJ, Locasale JW, et al. 2016. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat Immunol. 17(12):1459–1466. doi:10.1038/ni.3577.
   PubMed Web of Science ®Google Scholar
• Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N. 2003. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 13(4):554–573. doi:10.1111/j.1750-3639.2003.tb00485.x.
   PubMed Web of Science ®Google Scholar
• Guijas C, Montenegro-Burke JR, Warth B, Spilker ME, Siuzdak G. 2018. Metabolomics activity screening for identifying metabolites that modulate phenotype. Nat Biotechnol. 36(4):316–320. doi:10.1038/nbt.4101.
   PubMed Web of Science ®Google Scholar
• Han H-S, Kang G, Kim JS, Choi BH, Koo S-H. 2016. Regulation of glucose metabolism from a liver-centric perspective. Exp Mol Med. 48(3):e218–e218. doi:10.1038/emm.2015.122.
   PubMed Web of Science ®Google Scholar
• Hanlon MM, McGarry T, Marzaioli V, Amaechi S, Song Q, Nagpal S, Veale DJ, Fearon U. 2022. Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations. Rheumatology. doi:10.1093/rheumatology/keac640.
   PubMed Web of Science ®Google Scholar
• Hanly JG. 2014. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol. 10(6):338–347. doi:10.1038/nrrheum.2014.15.
   PubMed Web of Science ®Google Scholar
• He D, Mao Q, Jia J, Wang Z, Liu Y, Liu T, Luo B, Zhang Z. 2022. Pentose phosphate pathway regulates tolerogenic apoptotic cell clearance and immune tolerance. Front Immunol. 12. doi:10.3389/fimmu.2021.797091.
   Web of Science ®Google Scholar
• He L. 2020. Metformin and systemic metabolism. Trends Pharmacol Sci. 41(11):868–881. doi:10.1016/j.tips.2020.09.001.
   PubMed Web of Science ®Google Scholar
• Henderson J, Duffy L, Stratton R, Ford D, O’Reilly S. 2020. Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis. J Cell Mol Med. 24(23):14026–14038. doi:10.1111/jcmm.16013.
   PubMed Web of Science ®Google Scholar
• Henderson J, O’Reilly S. 2021. The emerging role of metabolism in fibrosis. Trends Endocrinol Metab. 32(8):639–653. doi:10.1016/j.tem.2021.05.003.
   PubMed Web of Science ®Google Scholar
• Hochrein SM, Wu H, Eckstein M, Arrigoni L, Herman JS, Schumacher F, Gerecke C, Rosenfeldt M, Grün D, Kleuser B, et al. 2022. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab. 34(4):516–532.e11. doi:10.1016/j.cmet.2022.02.015.
   PubMed Web of Science ®Google Scholar
• Jung SM, Kim W-U. 2022. Targeted immunotherapy for autoimmune disease. Immune Netw. 22(1):e9. doi:10.4110/in.2022.22.e9.
   PubMed Web of Science ®Google Scholar
• Kaskow BJ, Baecher-Allan C. 2018. Effector T cells in multiple sclerosis. Cold Spring Harb Perspect Med. 8(4):a029025. doi:10.1101/cshperspect.a029025.
   PubMed Web of Science ®Google Scholar
• Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J, Strasburger H, Herbst L, Alexis M, Karnell J, et al. 2019. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat Commun. 10(1):3887. doi:10.1038/s41467-019-11638-3.
   PubMedGoogle Scholar
• Koju N, Qin Z, Sheng R. 2022. Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe? Acta Pharmacol Sin. 43(8):1889–1904. doi:10.1038/s41401-021-00838-7.
   PubMed Web of Science ®Google Scholar
• Kolan SS, Li G, Wik JA, Malachin G, Guo S, Kolan P, Skålhegg BS. 2020. Cellular metabolism dictates T cell effector function in health and disease. Scand J Immunol. 92(5):e12956. doi:10.1111/sji.12956.
   PubMed Web of Science ®Google Scholar
• Kolliniati O, Ieronymaki E, Vergadi E, Tsatsanis C. 2022. Metabolic regulation of macrophage activation. J Innate Immun. 14(1):51–68. doi:10.1159/000516780.
   PubMed Web of Science ®Google Scholar
• Kornberg MD, Bhargava P, Kim PM, Putluri V, Snowman AM, Putluri N, Calabresi PA, Snyder SH. 2018. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science. 360(6387):449–453. doi:10.1126/science.aan4665.
   PubMed Web of Science ®Google Scholar
• Kottmann RM, Kulkarni AA, Smolnycki KA, Lyda E, Dahanayake T, Salibi R, Honnons S, Jones C, Isern NG, Hu JZ, et al. 2012. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β. Am J Respir Crit Care Med. 186(8):740–751. doi:10.1164/rccm.201201-0084OC.
   PubMed Web of Science ®Google Scholar
• La Torre D, Seppänen-Laakso T, Larsson HE, Hyötyläinen T, Ivarsson SA, Lernmark A, Oresic M, DiPiS Study Group. 2013. Decreased cord-blood phospholipids in young age-at-onset type 1 diabetes. Diabetes. 62(11):3951–3956. doi:10.2337/db13-0215.
   PubMed Web of Science ®Google Scholar
• Lerner A, Jeremias P, Matthias T. 2015. The world incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis. 3(4):151–155. doi:10.12691/ijcd-3-4-8.
   Google Scholar
• Li W, Qu G, Choi S, Cornaby C, Titov AA, Kanda N, Teng X, Wang H, Morel L. 2019. Targeting T cell activation and lupus autoimmune phenotypes by inhibiting glucose transporters. Front Immunol. 10. doi:10.3389/fimmu.2019.00833.
   Web of Science ®Google Scholar
• Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB, Kaplan MJ. 2016. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 22(2):146–153. doi:10.1038/nm.4027.
   PubMed Web of Science ®Google Scholar
• Mahad D, Ziabreva I, Lassmann H, Turnbull D. 2008. Mitochondrial defects in acute multiple sclerosis lesions. Brain. 131(7):1722–1735. doi:10.1093/brain/awn105.
   PubMedGoogle Scholar
• Mahmoud DE, Kaabachi W, Sassi N, Tarhouni L, Rekik S, Jemmali S, Sehli H, Kallel-Sellami M, Cheour E, Laadhar L. 2022. The synovial fluid fibroblast-like synoviocyte: a long-neglected piece in the puzzle of rheumatoid arthritis pathogenesis. Front Immunol. 13. doi:10.3389/fimmu.2022.942417.
   Web of Science ®Google Scholar
• Martins CP, New LA, Connor EC, Previte DM, Cargill KR, Tse IL, Sims- Lucas S, Piganelli JD. 2021. Glycolysis inhibition induces functional and metabolic exhaustion of CD4+ T cells in type 1 diabetes. Front Immunol. 12:669456. doi:10.3389/fimmu.2021.669456.
   PubMed Web of Science ®Google Scholar
• Masoumi M, Mehrabzadeh M, Mahmoudzehi S, Mousavi MJ, Jamalzehi S, Sahebkar A, Karami J. 2020. Role of glucose metabolism in aggressive phenotype of fibroblast-like synoviocytes: latest evidence and therapeutic approaches in rheumatoid arthritis. Int Immunopharmacol. 89:107064. doi:10.1016/j.intimp.2020.107064.
   PubMed Web of Science ®Google Scholar
• Miller FW. 2023. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 80:102266. doi:10.1016/j.coi.2022.102266.
   PubMed Web of Science ®Google Scholar
• Mohammadnezhad L, Shekarkar Azgomi M, La Manna MP, Sireci G, Rizzo C, Badami GD, Tamburini B, Dieli F, Guggino G, Caccamo N. 2022. Metabolic reprogramming of innate immune cells as a possible source of new therapeutic approaches in autoimmunity. Cells. 11(10):1663. doi:10.3390/cells11101663.
   PubMed Web of Science ®Google Scholar
• Nave K-A. 2010. Myelination and the trophic support of long axons. Nat Rev Neurosci. 11(4):275–283. doi:10.1038/nrn2797.
   PubMed Web of Science ®Google Scholar
• Negrotto L, Farez MF, Correale J. 2016. Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis. JAMA Neurol. 73(5):520–528. doi:10.1001/jamaneurol.2015.4807.
   PubMed Web of Science ®Google Scholar
• Neumann B, Baror R, Zhao C, Segel M, Dietmann S, Rawji KS, Foerster S, McClain CR, Chalut K, van Wijngaarden P, Franklin RJM. 2019. Metformin restores CNS remyelination capacity by rejuvenating aged stem cells. Cell Stem Cell. 25(4):473–485.e8. doi:10.1016/j.stem.2019.08.015.
   PubMed Web of Science ®Google Scholar
• Noyes K, Weinstock-Guttman B. 2013. Impact of diagnosis and early treatment on the course of multiple sclerosis. PubMed. 19(17 Suppl):s321–s331. https://pubmed.ncbi.nlm.nih.gov/24494633.
   Google Scholar
• Nygaard G, Firestein GS. 2020. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 16(6):316–333. doi:10.1038/s41584-020-0413-5.
   PubMed Web of Science ®Google Scholar
• Okano T, Saegusa J, Nishimura K, Takahashi S, Sendo S, Ueda Y, Morinobu A. 2017. 3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17/Treg cell differentiation and suppressing dendritic cell activation. Sci Rep. 7(1):42412. doi:10.1038/srep42412.
   PubMedGoogle Scholar
• Oksuzoglu K, Ozen G, Inanir S, Direskeneli RH. 2015. Flip-flop phenomenon in systemic sclerosis on fluorodeoxyglucose positron emission tomography/computed tomography. Indian J Nucl Med. 30(4):350. doi:10.4103/0972-3919.164018.
   PubMedGoogle Scholar
• O’Neill LAJ, Pearce EJ. 2016. Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 213(1):15–23. doi:10.1084/jem.20151570.
   PubMed Web of Science ®Google Scholar
• Oresic M, Gopalacharyulu P, Mykkänen J, Lietzen N, Mäkinen M, Nygren H, Simell S, Simell V, Hyöty H, Veijola R, et al. 2013. Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes. Diabetes. 62(9):3268–3274. doi:10.2337/db13-0159.
   PubMed Web of Science ®Google Scholar
• Padgett LE, Broniowska KA, Hansen PA, Corbett JA, Tse HM. 2013. The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann N Y Acad Sci. 1281(1):16–35. doi:10.1111/j.1749-6632.2012.06826.x.
   PubMedGoogle Scholar
• Panday A, Sahoo MK, Osorio D, Batra S. 2015. NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell Mol Immunol. 12(1):5–23. doi:10.1038/cmi.2014.89.
   PubMed Web of Science ®Google Scholar
• Park D, Lim G, Yoon S-J, Yi H-S, Choi DW. 2022. The role of immunomodulatory metabolites in shaping the inflammatory response of macrophages. BMB Rep. 55(11):519–527. doi:10.5483/BMBRep.2022.55.11.128.
   PubMed Web of Science ®Google Scholar
• Patel CH, Leone RD, Horton MR, Powell JD. 2019. Targeting metabolism to regulate immune responses in autoimmunity and cancer. Nat Rev Drug Discov. 18(9):669–688. doi:10.1038/s41573-019-0032-5.
   PubMed Web of Science ®Google Scholar
• Patra KC, Hay N. 2014. The pentose phosphate pathway and cancer. Trends Biochem Sci. 39(8):347–354. doi:10.1016/j.tibs.2014.06.005.
   PubMed Web of Science ®Google Scholar
• Pearce EL, Pearce EJ. 2013. Metabolic pathways in immune cell activation and quiescence. Immunity. 38(4):633–643. doi:10.1016/j.immuni.2013.04.005.
   PubMed Web of Science ®Google Scholar
• Pearce EL, Poffenberger MC, Chang C-H, Jones RG. 2013. Fueling immunity: insights into metabolism and lymphocyte function. Science. 342(6155):1242454. doi:10.1126/science.1242454.
   PubMedGoogle Scholar
• Perl A, Gergely P, Banki K. 2004. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus. Int Rev Immunol. 23(3–4):293–313. doi:10.1080/08830180490452576.
   PubMed Web of Science ®Google Scholar
• Pflueger M, Seppänen-Laakso T, Suortti T, Hyötyläinen T, Achenbach P, Bonifacio E, Orešič M, Ziegler A-G. 2011. Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes. 60(11):2740–2747. doi:10.2337/db10-1652.
   PubMed Web of Science ®Google Scholar
• Previte DM, O’Connor EC, Novak EA, Martins CP, Mollen KP, Piganelli JD. 2017. Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation. PLoS One. 12(4):e0175549. doi:10.1371/journal.pone.0175549.
   PubMed Web of Science ®Google Scholar
• Quiñonez-Flores CM, González-Chávez SA, Pacheco-Tena C. 2016. Hypoxia and its implications in rheumatoid arthritis. J Biomed Sci. 23(1):62. doi:10.1186/s12929-016-0281-0.
   PubMed Web of Science ®Google Scholar
• Ramos-Martinez JI. 2017. The regulation of the pentose phosphate pathway: remember Krebs. Arch Biochem Biophys. 614:50–52. doi:10.1016/j.abb.2016.12.012.
   PubMed Web of Science ®Google Scholar
• Renaud L, Da Silveira WA, Takamura N, Hardiman G, Feghali-Bostwick C. 2020. Prominence of IL6, IGF, TLR, and bioenergetics pathway perturbation in lung tissues of scleroderma patients with pulmonary fibrosis. Front Immunol. 11. doi:10.3389/fimmu.2020.00383.
   Web of Science ®Google Scholar
• Rodríguez-Prados J-C, Través PG, Cuenca J, Rico D, Aragonés J, Martín-Sanz P, Cascante M, Boscá L. 2010. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol. 185(1):605–614. doi:10.4049/jimmunol.0901698.
   PubMed Web of Science ®Google Scholar
• Rosenblum MD, Remedios KA, Abbas AK. 2015. Mechanisms of human autoimmunity. J Clin Invest. 125(6):2228–2233. doi:10.1172/JCI78088.
   PubMed Web of Science ®Google Scholar
• Schwartz RH. 2012. Historical overview of immunological tolerance. Cold Spring Harb Perspect Biol. 4(4):a006908. doi:10.1101/cshperspect.a006908.
   PubMed Web of Science ®Google Scholar
• Segal BM. 2019. The diversity of encephalitogenic CD4+ T cells in multiple sclerosis and its animal models. J Clin Med. 8(1):120. doi:10.3390/jcm8010120.
   PubMed Web of Science ®Google Scholar
• Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H. 2011. HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 208(7):1367–1376. doi:10.1084/jem.20110278.
   PubMed Web of Science ®Google Scholar
• Shyer JA, Flavell RA, Bailis W. 2020. Metabolic signaling in T cells. Cell Res. 30(8):649–659. doi:10.1038/s41422-020-0379-5.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K. 2018. Rheumatoid arthritis. Nat Rev Dis Primers. 4(1):1–23. doi:10.1038/nrdp.2018.1.
   PubMedGoogle Scholar
• Song G, Lu Q, Fan H, Zhang X, Ge L, Tian R, Wang S, Feng T, Pan J, Feng J, et al. 2019. Inhibition of hexokinases holds potential as treatment strategy for rheumatoid arthritis. Arthritis Res Ther. 21(1):87. doi:10.1186/s13075-019-1865-3.
   PubMedGoogle Scholar
• Streeter HB, Wraith DC. 2021. Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases. Curr Opin Immunol. 70:75–81. doi:10.1016/j.coi.2021.03.019.
   PubMed Web of Science ®Google Scholar
• Sysi-Aho M, Ermolov A, Gopalacharyulu PV, Tripathi A, Seppänen-Laakso T, Maukonen J, Mattila I, Ruohonen ST, Vähätalo L, Yetukuri L, et al. 2011. Metabolic regulation in progression to autoimmune diabetes. PLoS Comput Biol. 7(10):e1002257. doi:10.1371/journal.pcbi.1002257.
   PubMed Web of Science ®Google Scholar
• Tavazzi B, Batocchi AP, Amorini AM, Nociti V, D’Urso S, Longo S, Gullotta S, Picardi M, Lazzarino G. 2011. Serum metabolic profile in multiple sclerosis patients. Mult Scler Int. 2011:1–8. doi:10.1155/2011/167156.
   Google Scholar
• Tse HM, Milton MJ, Schreiner S, Profozich JL, Trucco M, Piganelli JD. 2007. Disruption of innate-mediated proinflammatory cytokine and reactive oxygen species third signal leads to antigen-specific hyporesponsiveness. J Immunol. 178(2):908–917. doi:10.4049/jimmunol.178.2.908.
   PubMed Web of Science ®Google Scholar
• Tsokos GC. 2011. Systemic lupus erythematosus. N Engl J Med. 365(22):2110–2121. doi:10.1056/NEJMra1100359.
   PubMed Web of Science ®Google Scholar
• Vadrucci M, Castellani M, Benti R. 2016. Active subcutaneous calcinosis demonstrated by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in a case of limited cutaneous systemic sclerosis. Indian J Nucl Med. 31(2):154. doi:10.4103/0972-3919.178335.
   PubMedGoogle Scholar
• Vander Heiden MG, DeBerardinis RJ. 2017. Understanding the intersections between metabolism and cancer biology. Cell. 168(4):657–669. doi:10.1016/j.cell.2016.12.039.
   PubMed Web of Science ®Google Scholar
• Volkmann ER, Andréasson K, Smith V. 2023. Systemic sclerosis. Lancet. 401(10373):304–318. doi:10.1016/S0140-6736(22)01692-0.
   PubMed Web of Science ®Google Scholar
• Wahl D, Petersen B, Warner R, Richardson B, Glick G, Opipari A. 2010. Characterization of the metabolic phenotype of chronically activated lymphocytes. Lupus. 19(13):1492–1501. doi:10.1177/0961203310373109.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang F-S, Gershwin ME. 2015. Human autoimmune diseases: a comprehensive update. J Intern Med. 278(4):369–395. doi:10.1111/joim.12395.
   PubMed Web of Science ®Google Scholar
• Weyand CM, Zeisbrich M, Goronzy JJ. 2017. Metabolic signatures of T-cells and macrophages in rheumatoid arthritis. Curr Opin Immunol. 46:112–120. doi:10.1016/j.coi.2017.04.010.
   PubMed Web of Science ®Google Scholar
• Woo YD, Jeong D, Chung DH. 2021. Development and functions of alveolar macrophages. Mol Cells. 44(5):292–300. doi:10.14348/molcells.2021.0058.
   PubMed Web of Science ®Google Scholar
• Xiao W, Wang R-S, Handy DE, Loscalzo J. 2018. Nad(H) and NADP(H). Redox couples and cellular energy metabolism. Antioxid Redox Signal. 28(3):251–272. doi:10.1089/ars.2017.7216.
   PubMed Web of Science ®Google Scholar
• Xie N, Tan Z, Banerjee S, Cui H, Ge J, Liu R-M, Bernard K, Thannickal VJ, Liu G. 2015. Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis. Am J Respir Crit Care Med. 192(12):1462–1474. doi:10.1164/rccm.201504-0780OC.
   PubMed Web of Science ®Google Scholar
• Xu J, Jiang C, Wang X, Geng M, Peng Y, Guo Y, Wang S, Li X, Tao P, Zhang F, et al. 2020. Upregulated PKM2 in macrophages exacerbates experimental arthritis via STAT1 signaling. J Immunol. 205(1):181–192. doi:10.4049/jimmunol.1901021.
   PubMed Web of Science ®Google Scholar
• Yin Y, Choi S-C, Xu Z, Perry DJ, Seay H, Croker BP, Sobel ES, Brusko TM, Morel L. 2015. Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med. 7(274):274ra18–274ra18. doi:10.1126/scitranslmed.aaa0835.
   PubMed Web of Science ®Google Scholar
• Yin Y, Choi S-C, Xu Z, Zeumer L, Kanda N, Croker BP, Morel L. 2016. Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus. J Immunol. 196(1):80–90. doi:10.4049/jimmunol.1501537.
   PubMed Web of Science ®Google Scholar
• Young SP, Kapoor SR, Viant MR, Byrne JJ, Filer A, Buckley CD, Kitas GD, Raza K. 2013. The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum. 65(8):2015–2023. doi:10.1002/art.38021.
   PubMedGoogle Scholar
• Zhao X, Fu J, Du J, Xu W. 2020. The role of D-3-phosphoglycerate dehydrogenase in cancer. Int J Biol Sci. 16(9):1495–1506. doi:10.7150/ijbs.41051.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yan X, Li X, Zheng Y, Li S, Chang X. 2016. PGK1, a glucose metabolism enzyme, may play an important role in rheumatoid arthritis. Inflamm Res. 65(10):815–825. doi:10.1007/s00011-016-0965-7.
   PubMed Web of Science ®Google Scholar
• Zorov DB, Juhaszova M, Sollott SJ. 2014. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 94(3):909–950. doi:10.1152/physrev.00026.2013.
   PubMed Web of Science ®Google Scholar
• Zou Y, Zeng S, Huang M, Qiu Q, Xiao Y, Shi M, Zhan Z, Liang L, Yang X, Xu H. 2017. Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis. Br J Pharmacol. 174(9):893–908. doi:10.1111/bph.13762.
   PubMed Web of Science ®Google Scholar